Compare Merck & Co., Inc. (MRK) vs Sunrun Inc (RUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Sunrun Inc — how do they compare? Merck & Co., Inc. trades at $146.19 (market cap $351.28B), while Sunrun Inc trades at $7.64 (market cap $1.83B). The key difference: Merck & Co., Inc. is far larger — about 192× Sunrun Inc's market cap, and Merck & Co., Inc. pays a 2.39% dividend while Sunrun Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and Sunrun Inc for 16 Days on average.
| MRK | RUN | |
|---|---|---|
Market Cap | $351.28B | $1.83B |
Volume | 7,969,665 | 8,672,852 |
Sector | Health | Energy |
52-Week High | $156.43 | $21.41 |
52-Week Low | $82.49 | $7.59 |
Typical Hold Time | 98 Days | 16 Days |
Enterprise Value | $398.04B | $16.35B |
Dividend Yield | 2.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $145.6, up 1.97% today, with a bearish technical signal but strong fundamental performance. Recent earnings have consistently beaten estimates, and the company is expanding its oncology pipeline through the acquisition of Terns Pharmaceuticals. Revenue growth is steady, with 2025 revenue at $65.01B and net income of $18.25B, though 2026 projections show a significant drop in net income to $3.2B. The stock is supported by a high analyst buy consensus of 68.42% and a price target of $158.78.
The outlook for MRK is mixed; strong earnings beats and strategic acquisitions provide upside potential, but high valuation ratios and a projected earnings decline in 2026 pose risks. Investors should weigh the company's robust profitability and analyst support against execution risks and market volatility.
Sunrun (RUN) trades at $7.55, down 0.79% recently, with technical indicators showing bearish momentum despite strong analyst support. The company demonstrates solid profitability with 35.29% gross margins and has beaten earnings expectations for three consecutive quarters. Recent partnerships with Tesla and Voltus highlight strategic positioning in distributed energy, though negative operating cash flow and high debt levels present challenges.
The stock appears fundamentally undervalued with a P/E of 5.16 and P/S of 0.59, while analyst consensus targets $16.33 representing 116% upside potential. However, persistent negative cash flows, high interest expenses, and solar industry headwinds from borrowing costs create significant execution risks that could limit near-term performance despite the attractive valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →
